title: Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.
abstract: Differences in the seroprevalence and unique pattern of parvovirus B19 (B19V) acute infections have been documented around the world. This study was conducted to estimate the seroprevalence of anti-parvovirus B19V IgG antibodies in the Israeli population and to assess the pattern of acute infection based on data from two laboratories in Israel. The overall IgG prevalence in the 1008 representative sera samples was 61·4% and the age-adjusted prevalence rate was 58·2%. Seropositivity was significantly associated with age, ranging from 25·7% in children aged 20 years. While no significant differences in seropositivity were detected between sexes and population groups, significantly lower seroprevalence was observed in older Jews born in Africa or Asia. Acute infection rates of 4·1% (234 cases) were found based on the positive IgM results identified in samples from 5663 individuals collected between 2008 and 2013. Annual peaks of infection were observed in 2008 and 2011-2012 and major seasonal peak of B19V IgM positivity was identified in June each year. The number of requests for B19V serology was significantly higher for women aged 20-39 years while the majority IgM-positive cases were identified in young children. With more than 30% of the adult population being susceptible to B19V infection, monitoring B19V status should be considered in specific risk groups such as pregnant women.
authors.affiliation: Central Virology Laboratory,Ministry of Health,Chaim Sheba Medical Center,Tel-Hashomer,Israel.
authors.forename: O
authors.initials: O
authors.lastname: Mor
authors.affiliation: Central Virology Laboratory,Ministry of Health,Chaim Sheba Medical Center,Tel-Hashomer,Israel.
authors.forename: I
authors.initials: I
authors.lastname: Ofir
authors.affiliation: Central Virology Laboratory,Ministry of Health,Chaim Sheba Medical Center,Tel-Hashomer,Israel.
authors.forename: R
authors.initials: R
authors.lastname: Pavel
authors.affiliation: Israel Center of Disease Control,Ministry of Health,Chaim Sheba Medical Center,Tel-Hashomer,Israel.
authors.forename: R
authors.initials: R
authors.lastname: Bassal
authors.affiliation: Virology Laboratory,Rambam Medical Center,Haifa,Israel.
authors.forename: Z
authors.initials: Z
authors.lastname: Kra-Oz
authors.affiliation: Department of Epidemiology and Preventive Medicine,School of Public Health,Sackler Faculty of Medicine,Tel-Aviv University,Tel-Aviv,Israel.
authors.forename: D
authors.initials: D
authors.lastname: Cohen
authors.affiliation: Department of Epidemiology and Preventive Medicine,School of Public Health,Sackler Faculty of Medicine,Tel-Aviv University,Tel-Aviv,Israel.
authors.forename: T
authors.initials: T
authors.lastname: Shohat
authors.affiliation: Central Virology Laboratory,Ministry of Health,Chaim Sheba Medical Center,Tel-Hashomer,Israel.
authors.forename: E
authors.initials: E
authors.lastname: Mendelson
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007223:Infant; D007231:Infant, Newborn; D007557:Israel / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010322:Parvoviridae Infections / Q000453:epidemiology* / Q000821:virology; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D015995:Prevalence; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D007075:Immunoglobulin M
keywords: Parvovirus; serology